AKT1 and lung carcinoma: Akt may contribute to chemoresistance and radioresistance: for example, over-expression of Akt1 has been reported to result in increased resistance of lung cancer cells (describe which cell lines) against a panel of various chemotherapeutic agents (doxorubicin, cisplatin, and mitoxantrone) (Hövelmann et al., 2004).